Regeneron Pharmaceuticals, Inc. (REGN)
828.72
-5.32
(-0.64%)
USD |
NASDAQ |
Aug 24, 16:00
834.55
+5.83
(+0.70%)
After-Hours: 20:00
Regeneron Pharmaceuticals Total Liabilities (Quarterly) : 10.02B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.02B |
| March 31, 2026 | 9.445B |
| December 31, 2025 | 9.302B |
| September 30, 2025 | 9.212B |
| June 30, 2025 | 8.280B |
| March 31, 2025 | 8.158B |
| December 31, 2024 | 8.499B |
| September 30, 2024 | 8.116B |
| June 30, 2024 | 7.881B |
| March 31, 2024 | 7.378B |
| December 31, 2023 | 7.158B |
| September 30, 2023 | 7.259B |
| June 30, 2023 | 6.640B |
| March 31, 2023 | 6.565B |
| December 31, 2022 | 6.609B |
| September 30, 2022 | 6.239B |
| June 30, 2022 | 6.518B |
| March 31, 2022 | 6.434B |
| December 31, 2021 | 6.666B |
| September 30, 2021 | 6.414B |
| June 30, 2021 | 6.359B |
| March 31, 2021 | 5.795B |
| December 31, 2020 | 6.138B |
| September 30, 2020 | 5.958B |
| June 30, 2020 | 5.371B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.624B |
| December 31, 2019 | 3.716B |
| September 30, 2019 | 3.435B |
| June 30, 2019 | 3.418B |
| March 31, 2019 | 3.410B |
| December 31, 2018 | 2.977B |
| September 30, 2018 | 2.937B |
| June 30, 2018 | 2.766B |
| March 31, 2018 | 2.805B |
| December 31, 2017 | 2.668B |
| September 30, 2017 | 2.650B |
| June 30, 2017 | 2.586B |
| March 31, 2017 | 2.951B |
| December 31, 2016 | 2.533B |
| September 30, 2016 | 2.337B |
| June 30, 2016 | 2.128B |
| March 31, 2016 | 2.139B |
| December 31, 2015 | 1.976B |
| September 30, 2015 | 1.886B |
| June 30, 2015 | 1.189B |
| March 31, 2015 | 1.227B |
| December 31, 2014 | 1.330B |
| September 30, 2014 | 1.188B |
| June 30, 2014 | 1.087B |
| March 31, 2014 | 1.049B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Gilead Sciences, Inc. | 37.62B |
| AbbVie, Inc. | 141.00B |
| Vertex Pharmaceuticals, Inc. | 7.175B |
| Amgen, Inc. | 83.95B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 41.73B |
| Shareholders Equity (Quarterly) | 31.71B |
| Debt to Equity Ratio | 0.0854 |
| Current Ratio | 3.335 |
| Net Debt Paydown Yield | -0.00% |